Physician profile
Brandy C Watson
NPI 1790996239
$1,109.32
in general payments reported to CMS, 2019-2025
19 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2021: $82.66 · 2022: $212 · 2023: $311 · 2024: $225 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.35 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $275.43 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $178.47 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $147.23 | 2019-2024 | |
| Medtronic Vascular, INC. | $77.87 | 2019 | |
| Abbvie INC. | $67.50 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $60.16 | 2023-2024 | Nuedexta |
| Abbott Laboratories | $36.13 | 2023-2024 | Freestyle Libre 3 |
| Boston Scientific Corporation | $32.80 | 2023 | Watchman Access System |
| Teva Pharmaceuticals USA, INC. | $32.26 | 2024 | Ajovy |
| Astrazeneca Pharmaceuticals LP | $30.58 | 2021 | |
| Exact Sciences Corporation | $29.71 | 2023-2024 | Cologuard Collection Kit |
| Neurocrine Biosciences, INC. | $28.74 | 2022 | |
| Sunovion Pharmaceuticals INC. | $18.94 | 2019 | |
| Glaxosmithkline, LLC. | $18.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.61 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.13 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.75 | 2021 | |
| Merck Sharp & Dohme LLC | $14.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.